Clopidogrel
- Product NDC
- 60505-3532
- 11-digit product format
- 605053532
- Labeler code
- 60505
- Product ID
- 60505-3532_936a8707-dc3c-ebe4-6a66-0f726988c764
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- clopidogrel bisulfate
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Apotex Corp.
- Application
- ANDA076274
- Marketing category
- ANDA
- Marketing start
- 2014-03-04
- Substance
- CLOPIDOGREL BISULFATE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Clopidogrel
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CLOPIDOGREL BISULFATE | 300 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 08I79HTP27 |
| Rxcui | 309362, 749196 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 60505-3532-5 | Clopidogrel | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | | 26 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CLOPIDOGREL BISULFATE | ACTIVE INGREDIENT | 08I79HTP27 | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [APOTEX CORP.] | 9 | |
| CLOPIDOGREL | ACTIVE MOIETY | A74586SNO7 | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [APOTEX CORP.] | 9 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [APOTEX CORP.] | 9 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [APOTEX CORP.] | 9 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [APOTEX CORP.] | 9 | |
| Hydroxypropyl Cellulose (Type H) | INACTIVE INGREDIENT | RFW2ET671P | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [APOTEX CORP.] | 9 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [APOTEX CORP.] | 9 | |
| METHYLCELLULOSE (15 CPS) | INACTIVE INGREDIENT | NPU9M2E6L8 | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [APOTEX CORP.] | 9 | |
| POLYETHYLENE GLYCOL 8000 | INACTIVE INGREDIENT | Q662QK8M3B | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [APOTEX CORP.] | 9 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [APOTEX CORP.] | 9 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [APOTEX CORP.] | 9 | |
| ZINC STEARATE | INACTIVE INGREDIENT | H92E6QA4FV | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [APOTEX CORP.] | 9 | |
| CLOPIDOGREL BISULFATE | ACTIVE INGREDIENT | 08I79HTP27 | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [MAJOR PHARMACEUTICALS] | 2 | |
| CLOPIDOGREL BISULFATE | ACTIVE INGREDIENT | 08I79HTP27 | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [AMERICAN HEALTH PACKAGING] | 2 | |
| CLOPIDOGREL | ACTIVE MOIETY | A74586SNO7 | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [MAJOR PHARMACEUTICALS] | 2 | |
| CLOPIDOGREL | ACTIVE MOIETY | A74586SNO7 | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [AMERICAN HEALTH PACKAGING] | 2 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [MAJOR PHARMACEUTICALS] | 2 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [AMERICAN HEALTH PACKAGING] | 2 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [MAJOR PHARMACEUTICALS] | 2 | |
| CROSPOVIDONE | INACTIVE INGREDIENT | 68401960MK | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [AMERICAN HEALTH PACKAGING] | 2 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [MAJOR PHARMACEUTICALS] | 2 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [AMERICAN HEALTH PACKAGING] | 2 | |
| HYDROXYPROPYL CELLULOSE (TYPE E) | INACTIVE INGREDIENT | 66O7AQV0RT | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [MAJOR PHARMACEUTICALS] | 2 | |
| HYDROXYPROPYL CELLULOSE (TYPE H) | INACTIVE INGREDIENT | RFW2ET671P | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [AMERICAN HEALTH PACKAGING] | 2 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [MAJOR PHARMACEUTICALS] | 2 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [AMERICAN HEALTH PACKAGING] | 2 | |
| METHYLCELLULOSE (15 MPA.S) | INACTIVE INGREDIENT | NPU9M2E6L8 | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [MAJOR PHARMACEUTICALS] | 2 | |
| METHYLCELLULOSE (15 MPA.S) | INACTIVE INGREDIENT | NPU9M2E6L8 | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [AMERICAN HEALTH PACKAGING] | 2 | |
| POLYETHYLENE GLYCOL 8000 | INACTIVE INGREDIENT | Q662QK8M3B | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [MAJOR PHARMACEUTICALS] | 2 | |
| POLYETHYLENE GLYCOL 8000 | INACTIVE INGREDIENT | Q662QK8M3B | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [AMERICAN HEALTH PACKAGING] | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [MAJOR PHARMACEUTICALS] | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [AMERICAN HEALTH PACKAGING] | 2 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [MAJOR PHARMACEUTICALS] | 2 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [AMERICAN HEALTH PACKAGING] | 2 | |
| ZINC STEARATE | INACTIVE INGREDIENT | H92E6QA4FV | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [MAJOR PHARMACEUTICALS] | 2 | |
| ZINC STEARATE | INACTIVE INGREDIENT | H92E6QA4FV | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [AMERICAN HEALTH PACKAGING] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 60505-3532 | CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET, FILM COATED [APOTEX CORP.] | 25 | Current NDC, Legacy NDC, 1 package rows | 20240925_edae8df1-caf9-ff72-1304-5ae8b355f8e7.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 60505-3532-5 | 60505353205 | 500 TABLET, FILM COATED in 1 BOTTLE (60505-3532-5) | 2014-03-04 | 0000-00-00 | No | No | Current |